ArticleJournal of clinical medicine2025

Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory Analysis.

Bruno Almeida Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.